Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for ...

Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger ...

Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA ...